PRMT5 is essential for the eIF4E-mediated 5'-cap dependent translation.

Area of Science:

• Molecular Biology
• Cell Biology
• Cancer Research

Background:

• Protein arginine methyltransferase 5 (PRMT5) is implicated in cell cycle progression, survival, and stress responses.
• The exact molecular mechanisms of PRMT5's roles are not fully elucidated.
• Previous work showed PRMT5's involvement in hypoxia adaptation via HIF-1α translation.

Purpose of the Study:

• To investigate if PRMT5 promotes cell proliferation by regulating the synthesis of oncoproteins c-Myc and cyclin D1.
• To explore the role of PRMT5 in 5'-cap dependent translation of proliferation-related mRNAs.

Main Methods:

• PRMT5 knockdown experiments.
• RNA immunoprecipitation (RIP) assays to identify RNA-protein interactions.
• Analysis of cell cycle progression and proliferation.
• Ectopic expression of eukaryotic initiation factor 4E (eIF4E).

Main Results:

• PRMT5 knockdown led to downregulation of c-Myc and cyclin D1.
• PRMT5 is essential for the interaction between eIF4E and the 5'-UTRs of HIF-1α, c-Myc, and cyclin D1 mRNAs.
• PRMT5 depletion caused G1 phase cell cycle arrest and inhibited proliferation.
• Ectopic eIF4E expression rescued cell cycle progression and proliferation in PRMT5-deficient cells.

Conclusions:

• PRMT5 regulates cell fate by controlling the 5'-cap dependent translation of proteins vital for proliferation and survival.
• PRMT5's mechanism involves facilitating the interaction of eIF4E with specific mRNA 5'-UTRs.
• Targeting PRMT5 could impact cancer cell proliferation and survival pathways.